| |
| |
|
| Insider
Information: |
Smith James Francis |
| Relationship: |
|
| City: |
Miami |
| State: |
FL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
62,900 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$5 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
62,900 |
|
|
| Total
Value |
$5 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Aphton Corp |
APHTQ |
Senior VP and CFO |
2005-04-21 |
40,000 |
2005-03-17 |
0 |
Premium* |
|
|
Echo Therapeutics Inc |
ECTE |
|
2013-12-18 |
22,900 |
2011-02-16 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
14 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ECTE |
Echo Therapeutics Inc |
|
– • – |
2013-12-18 |
4 |
A |
$0.00 |
$0 |
D/D |
14,500 |
22,900 |
0 |
- |
|
| ECTE |
Echo Therapeutics Inc |
|
– • – |
2013-10-01 |
4 |
A |
$0.00 |
$0 |
D/D |
400 |
8,400 |
0 |
- |
|
| ECTE |
Echo Therapeutics Inc |
|
– • – |
2013-07-01 |
4/A |
A |
$0.00 |
$0 |
D/D |
400 |
8,000 |
0 |
- |
|
| ECTE |
Echo Therapeutics Inc |
|
– • – |
2013-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
400 |
76,400 |
0 |
- |
|
| ECTE |
Echo Therapeutics Inc |
|
– • – |
2013-04-09 |
4 |
A |
$0.00 |
$0 |
D/D |
4,000 |
76,000 |
0 |
- |
|
| ECTE |
Echo Therapeutics Inc |
|
– • – |
2013-01-10 |
4 |
A |
$0.00 |
$0 |
D/D |
6,250 |
72,000 |
0 |
- |
|
| ECTE |
Echo Therapeutics Inc |
|
– • – |
2012-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
6,250 |
65,750 |
0 |
- |
|
| ECTE |
Echo Therapeutics Inc |
|
– • – |
2012-08-23 |
4 |
B |
$1.47 |
$9,408 |
D/D |
6,400 |
59,500 |
0.01 |
- |
|
| ECTE |
Echo Therapeutics Inc |
|
– • – |
2012-08-22 |
4 |
B |
$1.47 |
$19,992 |
D/D |
13,600 |
53,100 |
0.01 |
- |
|
| ECTE |
Echo Therapeutics Inc |
|
– • – |
2012-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
6,250 |
39,500 |
0 |
- |
|
| ECTE |
Echo Therapeutics Inc |
|
– • – |
2011-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
27,000 |
0 |
- |
|
| ECTE |
Echo Therapeutics Inc |
|
– • – |
2011-02-08 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
7,000 |
|
- |
|
| APHTQ |
Aphton Corp |
Senior VP and CFO |
• – – |
2005-04-21 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
40,000 |
|
- |
|
| APHTQ |
Aphton Corp |
Senior VP and CFO |
• – – |
2005-03-17 |
4 |
B |
$1.24 |
$18,600 |
D/D |
15,000 |
15,000 |
2.74 |
- |
|
14 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
